Reference - Detail
| RRC ID | 44429 |
|---|---|
| Author | Wang X, Li X, Ito A, Sogo Y, Ohno T. |
| Title | Pore size-dependent immunogenic activity of mesoporous silica-based adjuvants in cancer immunotherapy. |
| Journal | J Biomed Mater Res A |
| Abstract |
Commonly used aluminum hydroxide (Alum) adjuvant provokes a strong type 2 helper T cell (Th2) response for mediating antibody production but is rather ineffective for disease prevention that requires type 1 helper T cell (Th1) response for mediating cellular immunity in human vaccination. Here, for the purpose of inducing Th1 antitumor immunity, a mesoporous silica (MS)-based adjuvant is prepared. Three kinds of MS particles with nearly identical particle size and surface area but different pore sizes of 4, 7 and 10 nm were prepared. No serious in vitro cytotoxicity was observed for the MS particles at 5, 20, 50, and 100 μg/mL. Pathogen-associated molecular patterns (PAMPs) were immobilized with apatite (Ap) on MS to prepare the MS-based and PAMP-loaded adjuvants (MS-Ap-PAMP adjuvants). Macrophage-like cells cultured in the presence of MS-Ap-PAMP adjuvant with a MS pore size of 10 nm showed the maximum in vitro immunogenic activity. Injection of the MS-Ap-PAMP adjuvant with a MS pore size of 10 nm in combination with liquid nitrogen-treated tumor tissue (derived from Lewis lung carcinoma cells) to C57BL/6 mice markedly inhibited the development of rechallenged tumor in vivo, while no such antitumor immunity was induced in injection of Alum mixed with PAMP in combination with liquid nitrogen-treated tumor tissue. The MS-Ap-PAMP adjuvant contributed to the elicitation of a potent systemic Th1 antitumor immunity in vivo. |
| Volume | 102(4) |
| Pages | 967-74 |
| Published | 2014-4-1 |
| DOI | 10.1002/jbm.a.34783 |
| PMID | 23650285 |
| MeSH | Adjuvants, Immunologic / pharmacology Adjuvants, Immunologic / therapeutic use* Adsorption Animals Apatites / chemistry Carcinoma, Lewis Lung / drug therapy Carcinoma, Lewis Lung / immunology Cell Survival / drug effects Granulocyte-Macrophage Colony-Stimulating Factor / metabolism Humans Immunotherapy* Macrophages / drug effects Macrophages / metabolism Mice Mice, Inbred C57BL Microscopy, Electron, Scanning NIH 3T3 Cells Neoplasms / drug therapy* Neoplasms / immunology* Nitrogen Porosity Silicon Dioxide / chemistry* Spectroscopy, Fourier Transform Infrared X-Ray Diffraction |
| IF | 3.525 |
| Times Cited | 14 |
| WOS Category | ENGINEERING, BIOMEDICAL MATERIALS SCIENCE, BIOMATERIALS |
| Altmetric score |
オルトメトリクス指標項目
|
| The most frequently cited source | Patent(IFI CLAIMS) |
| Total number of mentions | 1 |
| Altmetric score changes over past 6months | 0.0 |
| Resource | |
| Human and Animal Cells | LLC(RCB0558) |